Barclays Increases Encompass Health (NYSE:EHC) Price Target to $108.00

Encompass Health (NYSE:EHC) had its target price boosted by research analysts at Barclays from $101.00 to $108.00 in a research note issued on Thursday, Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Barclays‘s price objective would indicate a potential upside of 30.97% from the stock’s current price.

Several other equities analysts have also recently weighed in on EHC. Stephens restated an “overweight” rating and set a $85.00 price target on shares of Encompass Health in a report on Tuesday, January 16th. William Blair restated an “outperform” rating on shares of Encompass Health in a report on Wednesday, February 7th. Mizuho raised their price target on Encompass Health from $93.00 to $95.00 and gave the company a “buy” rating in a report on Thursday. Royal Bank of Canada restated an “outperform” rating and set a $83.00 price target on shares of Encompass Health in a report on Friday, February 9th. Finally, Truist Financial raised their price objective on Encompass Health from $82.00 to $86.00 and gave the company a “buy” rating in a research note on Friday, February 9th. Eight research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and an average price target of $86.56.

Encompass Health Stock Performance

NYSE:EHC opened at $82.46 on Thursday. The company has a current ratio of 1.37, a quick ratio of 1.28 and a debt-to-equity ratio of 1.14. Encompass Health has a 12-month low of $57.55 and a 12-month high of $85.84. The stock has a 50-day moving average price of $78.25 and a 200 day moving average price of $70.87. The stock has a market capitalization of $8.26 billion, a P/E ratio of 22.29, a P/E/G ratio of 1.50 and a beta of 0.94.

Encompass Health (NYSE:EHC) last released its earnings results on Wednesday, April 24th. The company reported $1.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.93 by $0.19. The firm had revenue of $1.32 billion during the quarter, compared to analysts’ expectations of $1.27 billion. Encompass Health had a return on equity of 18.01% and a net margin of 7.60%. The firm’s revenue was up 13.4% on a year-over-year basis. During the same quarter last year, the business posted $0.88 earnings per share. Equities research analysts forecast that Encompass Health will post 4.04 EPS for the current fiscal year.

Institutional Investors Weigh In On Encompass Health

A number of institutional investors and hedge funds have recently modified their holdings of the business. New York State Teachers Retirement System lifted its stake in shares of Encompass Health by 6.8% during the 1st quarter. New York State Teachers Retirement System now owns 73,166 shares of the company’s stock worth $6,042,000 after acquiring an additional 4,670 shares during the last quarter. Horrell Capital Management Inc. lifted its stake in shares of Encompass Health by 0.5% during the 1st quarter. Horrell Capital Management Inc. now owns 29,371 shares of the company’s stock worth $2,425,000 after acquiring an additional 147 shares during the last quarter. Equitable Trust Co. lifted its stake in shares of Encompass Health by 69.4% during the 1st quarter. Equitable Trust Co. now owns 6,429 shares of the company’s stock worth $531,000 after acquiring an additional 2,634 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in shares of Encompass Health by 75.7% during the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 720,173 shares of the company’s stock worth $59,472,000 after acquiring an additional 310,285 shares during the last quarter. Finally, Rice Hall James & Associates LLC lifted its stake in shares of Encompass Health by 15.1% during the 1st quarter. Rice Hall James & Associates LLC now owns 55,111 shares of the company’s stock worth $4,551,000 after acquiring an additional 7,225 shares during the last quarter. 97.25% of the stock is owned by institutional investors.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.